Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2026-05-23 @ 12:41 PM
Study NCT ID:
NCT05704933
Status:
COMPLETED
Last Update Posted:
2025-10-20
First Post:
2023-01-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MCC-21273
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |